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Major depressive disorder (MDD) and cardiovascular diseases are intimately associated.
Depression is an independent risk factor for mortality in cardiovascular samples. Neuroen-
docrine dysfunctions in MDD are related to an overactive hypothalamus-pituitary-adrenal
(HPA) axis and increased sympathetic activity. Novel intervention strategies for MDD
include the non-invasive brain stimulation (NIBS) techniques such as repetitive transcra-
nial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS). In
fact, although these techniques have being increasingly used as a treatment for MDD,
their cardiovascular effects were not sufficiently investigated, which would be important
considering the dyad MDD/cardiovascular disorders. We investigated this issue through
a systematic review for published articles from the first date available to May 2012 in
MEDLINE and other databases, looking for main risk factors and surrogate markers for car-
diovascular disease such as: cortisol, heart rate variability (HRV), alcohol, smoking, obesity,
hypertension, glucose. We identified 37 articles (981 subjects) according to our eligibil-
ity criteria. Our main findings were that NIBS techniques might be effective strategies
for down-regulating HPA activity and regulating food, alcohol, and cigarette consumption.
NIBS’s effects on HRV and blood pressure presented mixed findings, with studies sug-
gesting that HRV values can decrease or remain unchanged after NIBS, while one study
found that rTMS increased blood pressure levels. Also, a single study showed that glucose
levels decrease after tDCS. However, most studies tested the acute effects after one sin-
gle session of rTMS/tDCS; therefore further studies are necessary to investigate whether
NIBS modifies cardiovascular risk factors in the long-term. In fact, considering the burden
of cardiac disease, further trials in cardiovascular, depressed, and non-depressed samples
using NIBS should be performed.
Keywords: transcranial direct current stimulation, major depressive disorder, repetitive transcranial magnetic
stimulation, systematic review, heart rate variability, hypothalamo-hypophyseal system
INTRODUCTION
Major depressive disorder (MDD) and cardiovascular disorders
are both prevalent and disabling conditions. It is expected that,
by 2020, they are going to be the second and the first main
causes of disability, respectively, worldwide (Murray and Lopez,
1997). These disorders present a complex relationship, with one
increasing the prevalence and severity of the other – e.g., subjects
with depression have an increased risk for myocardial infarction
(MI) while those with depression post-MI have increased risk of
mortality (Taylor et al., 2005; Whooley et al., 2008). However,
pharmacological treatments do not necessarily diminish cardio-
vascular risk, as shown in recent clinical trials in patients with
cardiovascular disease and depression (Jiang et al., 2011). Fur-
ther, tricyclic antidepressants and antiepileptic drugs (also used in
some types of depression) decrease heart rate variability (HRV),
which is a surrogate marker of cardiovascular illness (Kemp
et al., 2010; Lotufo et al., 2012). Likewise, tricyclics might also
increase levels of IL-6 and TNF-alpha that are pro-inflammatory
cytokines associated with cardiovascular risk (Maes et al., 2011).
Therefore, the development of treatments that are not only clin-
ically effective but also safe from a cardiovascular perspective is
needed.
In recent years, non-invasive brain stimulation (NIBS) tech-
niques, such as repetitive transcranial magnetic stimulation
(rTMS) and transcranial direct current stimulation (tDCS), have
been investigated as putative treatments for depression. Transcra-
nial magnetic stimulation (TMS) depolarizes neurons through
a potent, relatively focal, electromagnetic field that is generated
beneath a coil positioned over the scalp. When applied repetitively,
rTMS has therapeutic effects. Recent meta-analyses demonstrated
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that high-frequency (HF) rTMS (i.e., excitatory) over the left
dorsolateral prefrontal cortex (DLPFC) and low-frequency (LF)
rTMS (i.e., inhibitory) over the right DLPFC are effective treat-
ments for MDD (Schutter, 2009, 2010). In contrast to TMS, tDCS
applies weak, direct electric currents to the brain through relatively
large electrodes placed over the scalp (Brunoni et al., 2012a). For
MDD, the anode is placed over the area corresponding to the left
DLPFC. Recently, a meta-analysis (Kalu et al., 2012) and a large
randomized, clinical trial (Brunoni et al., in press) suggested that
tDCS might be an effective treatment for depression.
Therefore, considering that (1) cardiovascular disease and
depression are related conditions; (2) antidepressants might have
a hazardous impact in increasing cardiovascular risk and (3) NIBS
therapies are potential therapeutic interventions for depression,
we sought to systematically review the effects of such techniques
on cardiovascular risk factors. We looked for risk factors such as
increased blood pressure and serum glucose levels, obesity, alcohol
use, and smoking. We also included in our search strategy HRV and
hypercortisolism that are markers of cardiovascular risk. Impor-
tantly, we did not look specifically for studies with MDD, as we
anticipated that the total number of studies would be low. Rather,
our aim was to summarize current evidence of the effects of NIBS
techniques on cardiovascular risk factors and discuss their impli-
cations in the treatment of MDD. Nevertheless, our findings can
be generalized for other neuropsychiatric disorders in which phar-
macological treatment is associated with hazardous cardiovascular
effects.
MATERIALS AND METHODS
We performed a systematic review for published articles from the
first date available to May 2012 in the following databases: MED-
LINE, Scielo, and Web of Knowledge. According to our proposal,
the key search terms were:
#1 “TMS” (MeSH term) OR “tDCS” OR (“transcranial” AND
“stimulation”)
#2 “Hypothalamo-hypophyseal system” (MeSH term) OR
“hypothalamus-pituitary-adrenal (HPA) axis” OR “cortisol”
#3 “HRV” OR “RR variability”
#4 “Smoking”
#5 “Obesity” (MeSH term) OR “food”
#6 [“Alcohol” AND (“dependence” OR “abuse”)] OR “alcohol”
#7 “Blood pressure” OR “hypertension”
#8 “Glucose” OR “diabetes”
The key search term #1 was crossed with (Boolean term AND)
each other term. We included all original clinical studies written
in English, apart from studies in experimental animals. We also
examined reference lists in retrieved papers, and contacted experts
on the field for identifying additional articles.
RESULTS
Figure 1 depicts the search strategy and included articles. Table 1
describes each article individually. We identified 37 articles, cor-
responding to 40 studies, since some articles reported more than
one cardiovascular risk factor. We further discuss NIBS effects on
each risk factor.
HPA AXIS
Masur et al. (1991) evaluated cortisol plasma levels in healthy
volunteers, observing no specific rTMS effects. Later, Evers et al.
(2001) evaluated healthy subjects in a sham-controlled design,
finding that rTMS decreased cortisol serum levels; whereas Baeken
et al. (2009b) performed a sham-controlled study in healthy
women, finding no rTMS effects on the HPA axis. However, Baeken
et al. (2011) found, in another sample, that rTMS decreased corti-
sol levels when controlling for baseline state anxiety. Other studies
reported that rTMS decreased salivary cortisol levels in patients
with depression (Baeken et al., 2009a) and bulimia (Claudino
et al., 2010). Zwanzger et al. (2003, 2007) evaluated rTMS effects
on the “area under the curve” of cortisol response in two studies:
in depressed patients, the authors explored whether therapeutical
rTMS would change the cortisol response to the dexametha-
sone cortisol suppression test that is characteristically impaired
in depression, finding no rTMS effects. Later on, the authors
evaluated whether rTMS would decrease panic symptomatol-
ogy and cortisol response after experimentally induction of a
panic attack with CCK-4. They also found no specific rTMS
effects.
Raimundo et al. (2012) evaluated tDCS effects on corti-
sol plasma levels in healthy volunteers, with no specific effects.
Conversely, Binkofski et al. (2011) observed that anodal tDCS
decreased cortisol serum levels compared to sham. Finally,
Brunoni et al. (2012b) also found cortisol levels decreasing after
anodal tDCS coupled with negative imagery viewing, which is a
method to experimentally induce stress.
HEART RATE VARIABILITY
Yoshida et al. (2001) suggested that rTMS could activate the
sympathetic nervous system as LF power increased – however,
LF reflects both sympathetic and parasympathetic activity (ESC,
1996) and therefore a more appropriate conclusion would be that
rTMS activated both the sympathetic and parasympathetic sys-
tems. Udupa et al. (2007), in a randomized, controlled trial com-
pared HRV changes after escitalopram and rTMS in depressed sub-
jects, suggesting that rTMS not only improved depression but also
restored sympathovagal balance (i.e., increased HRV values), in
contrast with escitalopram. Finally, Goldie et al. (2010) described
that rTMS led to “decreased arousal levels” (i.e., decreased sym-
pathetic/increased parasympathetic activity), although the study
primary aim was to identify novel HRV measures, and not rTMS
effects on HRV per se.
Regarding tDCS, Vandermeeren et al. (2010) applied anodal,
cathodal, and sham tDCS in 30 healthy volunteers, finding no
specific effects on HRV. Conversely, Montenegro et al. (2011)
applied anodal tDCS over the left temporal area, observing HF
HRV increasing and LF-HRV decreasing; however, this effect was
observed only in highly fit athletes. Finally, Brunoni et al. (2012b)
found that anodal tDCS increased HF-HRV, particularly during
negative imagery viewing, suggesting that tDCS could interfere
favorably in stress responses elicited by negative imagery.
BLOOD PRESSURE
In a safety study, Jahanshahi et al. (1997) evaluated HF rTMS
in six healthy subjects, finding a trend (p= 0.06) for active
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FIGURE 1 | Flow chart of reviewed studies, according to PRISMA guidelines.The complete key search terms are described in the main text.
rTMS decreasing blood pressure. Jenkins et al. (2002) com-
pared the effects of rTMS on mood and blood pressure over
the left and right DLPFC finding that left but not right stimula-
tion decreased arterial pressure. Likewise, Knotkova et al. (2012),
in an open-label study, found that anodal tDCS over the left
DLPFC generally decreased blood pressure levels. In addition,
Binkofski et al. (2011) used anodal tDCS over the left primary
motor cortex, finding small but significant decrements on blood
pressure.
Conversely, Yozbatiran et al. (2009) found a small but signifi-
cant increase of systolic blood pressure after HF rTMS stimulation
over the ipsilesional primary motor cortex hand area in stroke
patients. Other studies with rTMS (Van den Eynde et al., 2010)
and tDCS (Vandermeeren et al., 2010) showed no changes in blood
pressure.
SERUM GLUCOSE LEVELS
Here, no rTMS studies matching our eligibility criteria were found.
For tDCS, Binkofski et al. (2011) studied male healthy volunteers
after active and sham tDCS stimulation. They observed increased
systemic glucose uptake tolerance in the active group.
FOOD INTAKE
Fregni et al. (2008b) found that desire for food consumption and
visual attention for food imagery decreased after tDCS, in a sham-
controlled design with healthy volunteers. Similar findings were
demonstrated in subsequent tDCS (Goldman et al., 2011) and
rTMS (Camus et al., 2009; Van den Eynde et al., 2010) studies.
Uher et al. (2005) found that self-reported food craving during
exposure to food remained stable before and after active rTMS,
while it increased after sham stimulation. However, Barth et al.
(2011) found that rTMS inhibited food craving no better than
sham rTMS.
SMOKING
Fregni et al. (2008a) compared active vs. sham tDCS over the left
DLPFC in smokers and found specific tDCS effects in decreas-
ing cue-induced craving. In fact, another study showed that
such effects were cumulative over 5 days (Boggio et al., 2009).
Amiaz et al. (2009) reported similar findings, and also that rTMS
decreased cigarette consumption. Conversely, Eichhammer et al.
(2003) reported that rTMS decreased cigarette smoking although
not levels of craving. Finally, Rose et al. (2011) found that
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Table 1 | Summary of reviewed studies.
N Sample Protocol Findings
HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) SYSTEM
Masur et al. (1991) 10 HS HF-rTMS at F3 rTMS had no impact on cortisol levels
Evers et al. (2001) 23 HS HF-rTMS at F3 rTMS mildly decreased cortisol levels
Zwanzger et al. (2003) 37 MDD HF-rTMS at F3 rTMS did not affect cortisol levels after the DEX/CRH test
Zwanzger et al. (2007) 11 HS LF-rTMS at F4 rTMS did not affect cortisol levels after panic induction with CCK-4
Baeken et al. (2009a) 20 MDD HF-rTMS at F3 rTMS decreased cortisol immediately and after 30 min
Baeken et al. (2009b) 54 HS HF-rTMS at F3 or F4 rTMS had no impact on salivary cortisol levels
Baeken et al. (2011) 24 HS HF-rTMS at F4 Baseline anxiety modified cortisol expression after rTMS
Raimundo et al. (2012) 50 HS atDCS at C3 rTMS had no impact on cortisol levels
Binkofski et al. (2011) 15 HS atDCS at M3 atDCS decreased cortisol levels
Brunoni et al. (2012b) 20 HS atDCS at F3/ctDCS at F4 and
vice-versa
atDCS at F3 decreased cortisol levels
HEART RATEVARIABILITY (HRV)
Yoshida et al. (2001) 32 HS LF-rTMS at Cz rTMS increased low-frequency HRV
Udupa et al. (2007) 52 MDD HF-rTMS at F3 rTMS improved sympathovagal balance
Goldie et al. (2010) 6 HS Unclear HRV effectively measures arousal levels
Vandermeeren et al. (2010) 30 HS atDCS or ctDCS at Fz No differences in HRV between groups
Montenegro et al. (2011) 20 HS atDCS at T3 Sympathovagal balance decreased only in athletes
Brunoni et al. (2012b) 20 HS aTDCS at F3/ctDCS at F4 and
vice-versa
atDCS at F3 increased high-frequency HRV during negative imagery
BLOOD PRESSURE (BP)
Jahanshahi et al. (1997) 6 HS HF-rTMS at M3 HF-rTMS showed a trend to decrease BP (p=0.06)
Jenkins et al. (2002) 19 HS LF-rTMS at F3 or F4 Left but not right rTMS decreased BP
Yozbatiran et al. (2009) 12 Stroke HF-rTMS at M1 rTMS increased BP
Vandermeeren et al. (2010) 30 HS atDCS at Fz No differences in BP between groups
Van den Eynde et al. (2011) 38 BN HF-rTMS at F3 No effects in BP between groups
Binkofski et al. (2011) 15 HS atDCS at M3 tDCS decreased BP
Knotkova et al. (2012) 8 MDD aTDCS at F3 BP initially increased and then decreased after tDCS
GLUCOSE LEVELS
Binkofski et al. (2011) 15 HS atDCS at M3 tDCS increased glucose tolerance
FOOD INTAKE
Uher et al. (2005) 28 HS HF-rTMS at F3 Food craving increased after sham, but not after real stimulation
Fregni et al. (2008b) 23 HS aTDCS at F3/ctDCS at F4 and
vice-versa
tDCS decreased food craving
Camus et al. (2009) 56 HS HF-rTMS at F4 rTMS decreased increased evaluation for food
Van den Eynde et al. (2010) 38 BN HF-rTMS at F3 rTMS decreased urge to eat and binge-eating episodes
Barth et al. (2011) 10 HS HF-rTMS at F3 Prefrontal rTMS inhibited food cravings no better than sham rTMS
Goldman et al. (2011) 19 HS atDCS at F4/ctDCS at F3 tDCS decreased food craving
NICOTINE DEPENDENCE
Eichhammer et al. (2003) 14 Smokers HF-rTMS at F3 rTMS reduced cigarette smoking
Fregni et al. (2008a) 24 Smokers atDCS at F3 or F4 Left or right tDCS reduced craving
Amiaz et al. (2009) 48 Smokers HF-rTMS at F3 rTMS reduced cigarette consumption and craving
Boggio et al. (2009) 27 Smokers atDCS at F3 tDCS decreased craving after smoking cue exposure
Rose et al. (2011) 15 Smokers HF-rTMS and LF-rTMS at SFG Differential effects of craving according to type of stimulation
ALCOHOL DEPENDENCE (AD)
Boggio et al. (2008) 13 AD aTDCS at F3/ctDCS at F4 tDCS decreased alcohol craving
Mishra et al. (2010) 45 AD HF-rTMS at F4 rTMS had significant anticraving effects in alcohol dependence
Höppner et al. (2011) 19 AD HF-rTMS at F3 No differences in craving and mood between groups
Herremans et al. (2012) 36 AD HF-rTMS at F4 No significant effects on alcohol craving
Nakamura-Palacios et al. (2012) 49 AD HF-rTMS at F3 tDCS increased frontal activity for Lesch IV alcoholics
HS, healthy subjects; MDD, major depressive disorder; BN, bulimia nervosa; AD, alcohol dependence; HF- and LF-rTMS, high-frequency and low-frequency repetitive
transcranial magnetic stimulation, respectively; atDCS, anodal transcranial direct current stimulation; ctDCS, cathodal transcranial direct current stimulation; BP, blood
pressure; HRV, heart rate variability; F3 and F4, left and right dorsolateral prefrontal cortical area; M3, left motor cortical area; T3, left temporal area; SFG, superior
frontal gyrus.
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HF-rTMS over the superior frontal gyrus increased craving after
smoking cue presentations, while it decreased craving after neutral
cue ones.
ALCOHOL CONSUMPTION
Herremans et al. (2012) showed no rTMS effects on alcohol crav-
ing in alcohol dependent patients. Conversely, Mishra et al. (2010)
reported positive findings for rTMS in reducing alcohol craving.
Höppner et al. (2011) showed mixed findings: although rTMS had
no effect on alcohol craving, the authors found that real vs. sham
rTMS increased the attentional blink on alcohol-related pictures.
Regarding tDCS, Boggio et al. (2008) found that active tDCS
decreased alcohol craving in patients with alcohol dependence.
Further, Nakamura-Palacios et al. (2012) found that active vs.
sham tDCS increased cognitive performance and prefrontal
activity in Lesch IV alcoholics.
DISCUSSION
In this systematic review, we evaluated 37 studies (981 subjects)
addressing the effects of NIBS techniques on several risk factors.
We found that: (1) cortisol levels decrease or remain unchanged
after NIBS; (2) NIBS effects on HRV and blood pressure pre-
sented mixed findings, with studies suggesting that HRV values can
decrease or remain unchanged after NIBS (one study found that
rTMS increased blood pressure levels); (3) a single study showed
that glucose levels decrease after tDCS; (4) most studies found
that NIBS can effectively decrease craving for alcohol, smoking,
and food intake. We further discuss these findings.
First, some limitations should be underscored. Although the
studies generally presented adequate methodology in terms of
design and assessment, most of them explored the effects of
NIBS after one single session. In addition, most studies were
exploratory, without a clearly defined hypothesis. Therefore, the
evidence here presented should be considered preliminary and
hypothesis-driven for further studies.
The effects of NIBS on the HPA axis and cardiovascular mech-
anisms are likely to occur via a top-down modulation, i.e., changes
in cortical activity that subsequently modify the activity of centers
related to hormonal and cardiovascular regulation that are situated
in subcortical areas and in the brain stem. Of note, NIBS effects on
these systems occurred mostly in the context of stress response –
e.g., negative image visualization (Brunoni et al., 2012b) and 16 h
fasting (Binkofski et al., 2011) or in clinical samples, such as depres-
sion (Baeken et al., 2009a), bulimia (Claudino et al., 2010), and
anxiety (Baeken et al., 2011). Likewise, such effects occurred pri-
marily during neuromodulation of DLPFC, an area implicated
in the pathophysiology of stress and affective disorders (Koenigs
and Grafman, 2009). This suggests that NIBS effects might not
act on these systems during their steady state; but rather when
they are being activated – for instance, during a stress response.
Further studies should investigate in which conditions blood pres-
sure and cortisol expression can be modulated by NIBS; and also
which brain areas should be targeted. In this context, using com-
puter simulated models and/or neuroimaging studies to identify
which brain areas are activated during brain stimulation might
help to identify cortical areas that could be targeted in order to
indirectly modulate the subcortical and brain stem areas related
to cardiovascular control. Another option is to investigate the
use of novel NIBS techniques, such as “deep rTMS” (Levkovitz
et al., 2007) and “high-definition” tDCS (Minhas et al., 2010) that
can theoretically target deeper brain areas and/or induce more
focalized stimuli as to directly modulate those areas.
Most reviewed studies showed that NIBS effectively regulated
craving and consumption for food, alcohol, and cigarette smok-
ing. This is in agreement with the putative role of the prefrontal
cortex as a brain region related to decision-making, either of
non-emotional (“cold cognition”) and emotional (“hot cogni-
tion”) content (Koenigs and Grafman, 2009), the latter including
also the inhibitory control of appetitive impulses. This brain area
is also connected with subcortical areas related to the “reward
system,” which includes the ventral tegmental area and nucleus
accumbens (Fecteau et al., 2010). Modulation of food, alcohol,
and cigarette intake could be a crucial contribution of NIBS for
the cardiovascular field, since most risk factors are directly associ-
ated with poor dietary and lifestyle choices. However, since most
studies evaluated the acute effects of tDCS, further investiga-
tion should focus on the long-term effects of tDCS in regulating
craving.
Finally, Binkofski et al. (2011) observed increased systemic
glucose turnover with active tDCS. This is a proxy for insulin
resistance that is impaired in diabetes mellitus. The authors sug-
gested that their findings could be explained by the activation of
ATP-dependent potassium channels (KATP) by tDCS in the hypo-
thalamus, which would inhibit hepatic gluconeogenesis. Further
studies could evaluate whether tDCS modifies other mechanisms
of insulin metabolism in healthy and clinical samples.
IMPLICATIONS FOR MDD TREATMENT
The activation of the HPA axis is an important link between MDD
and cardiovascular illness (Maes et al., 2011). Hypercortisolism
leads to a dysregulation of glucose, lipid metabolism, and blood
pressure, which contributes to the metabolic syndrome. Moreover,
hypercortisolism has unfavorable effects on the immune system. In
our review, we observed that some NIBS studies decreased cortisol
levels, suggesting that these techniques might induce modulatory
top-down effects that lead to a down-regulation of the HPA axis.
Further research should explore whether such effects persist over
time – for instance, evaluating other cortisol measures, such as
cortisol awakening response and cortisol daily curve.
Major depressive disorder is also related to an autonomic shift
toward sympathetic predominance, which also increases inflam-
matory response in the endothelium and platelet activation, has-
tening the formation of atherosclerotic plaques (Lett et al., 2004).
This sympathetic tone shift boosts sympatho-adrenal response,
increasing catecholamines secretion in adrenal medulla, leading to
a hypercortisolemic and hypercatecholaminergic state, contribut-
ing to this physiopathological mechanism. Our results showed
that HRV is either non-affected or increased after NIBS (Evers
et al., 2001). A possible mechanism of action for NIBS is also top-
down modulation, through activity increasing in cortical regions
and down-regulation of the sympatho-adrenomedullary system,
leading to a decrease in sympathetic activity.
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OTHER BRAIN STIMULATION TECHNIQUES
Although NIBS seems to down-regulate stress response, this
might not necessarily be true to other forms of brain stimula-
tion. For instance, electroconvulsive therapy (ECT) has a char-
acteristic biphasic response, i.e., a parasympathetic phase that
lasts for approximately 20 s followed by a sympathetic phase
of approximately 1 min (Geersing et al., 2011). In addition,
repetitive trans-spinal magnetic stimulation, i.e., a TMS coil
applied over the sixth and seventh cervical vertebrae, showed
no difference between sham and active groups on measures
of HRV (Paxton et al., 2011). However, deep brain stim-
ulation seems to have favorable effects over the autonomic
nervous system in patients with Parkinson’s disease, in con-
trast to levodopa that has unfavorable effects (Ludwig et al.,
2007).
Another potentially interesting therapy is vagus nerve stim-
ulation (VNS). Recently, a HRV meta-analysis of epilepsy and
epilepsy treatment suggested that could have favorable effects on
sympathovagal balance, presumably through direct stimulation of
the vagus nerve (Lotufo et al., 2012). Further, it also seems to be
a safe therapy from a cardiovascular perspective, according to a
recent long-term follow-up in depressed patients (Bajbouj et al.,
2010).
CONCLUSION
We found that NIBS techniques, used in neuropsychology and
neuropsychiatry,might also exert effects in pathological endocrine,
immune, and neural events associated with cardiovascular disease,
particularly in managing the cardiovascular reactivity induced by
stress and inhibiting food and cigarette consumption. For MDD,
these techniques contrast with antidepressants not only due to the
absence of pharmacological interaction, but also possibly in terms
of cardiovascular effects. Nevertheless, further studies are needed
to determine the scope of these interventions, defining their effect
power and indications for regulating cardiovascular and metabolic
parameters.
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